She got a $911,400 bill for treatment that was supposed to be free. The autism-therapy industry is booming—and so are the billing abuses.

Insurers warn of fraud and exorbitant charges from providers, including one that stuck a parent with…

Abivax Bowel-Disease Drug Hits Goals in Trial, But Shares Plunge on Safety Worries

Shares fell sharply after the biotech said some patients developed cancer in a late-stage clinical trial…

Health Care Roundup: Market Talk

Find insight on Abivax, Bayer and more in the latest Market Talks covering Health Care.

Energy & Utilities Roundup: Market Talk

Find insight on crude futures, Equinor in the latest Market Talks covering energy and utilities.

Russia Resupplies Its Syria Air Base, Hanging On to a Strategic Foothold

The mission by a sanctioned ship indicates that the site survived the overthrow of Moscow’s allied…

U.S. Presses Neutral Oman to Pick a Side and Cut Ties With Iran

The country, which has walked a fine line between Washington and Tehran, is losing its footing…

How a Far-Right Outsider Became the Front-Runner in Colombia’s Presidential Race

Abelardo de la Espriella is on the cusp of victory by promising to crush drug smuggling…

China’s Chip Ambitions Run Into a Global Tech Wall

Plus, Huawei will likely trail rivals by six to eight years by 2031 despite its innovations.

Russia’s Attacks on Civilians Grow More Vicious as It Stalls on Battlefield

The heavy nationwide drone and missile strikes killed at least 18 people and injured over 100,…

Does the World Need Chinese Rare Earths? Not Necessarily, Say These Companies

Beijing’s move to choke off the supply spurred companies to develop new products that could potentially…